Dysglycaemia and risk of cardiovascular disease

被引：138
|
作者：
Gerstein, HC
Yusuf, S
机构：
[1] MCMASTER UNIV, CHEDOKE MCMASTER HOSP, DEPT MED, DIABET CARE & RES CTR, HAMILTON, ON L8N 3Z5, CANADA
[2] HAMILTON CIV HOSP, RES CTR, PREVENT CARDIOL & THERAPEUT PROGRAMME, HAMILTON, ON, CANADA
来源：
LANCET | 1996年 / 347卷 / 9006期
关键词：
D O I：
10.1016/S0140-6736(96)91420-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：949 / 950
页数：2
相关论文
共 50 条
  • [1] Dysglycaemia and risk of cardiovascular disease - Reply
    Gerstein, HC
    Yusuf, S
    LANCET, 1996, 347 (9018): : 1834 - 1835
  • [2] Dysglycaemia: a cardiovascular risk factor
    Gerstein, HC
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 40 : S9 - S14
  • [3] Prevalence of Undiagnosed Dysglycaemia in Adults at High Risk of Cardiovascular Disease
    Price, Hermione C.
    Griffin, Simon J.
    Holman, Rury R.
    DIABETES, 2009, 58 : A639 - A639
  • [4] Dysglycaemia in cardiovascular disease: what's the best glycaemic risk predictor?
    Del Prato, Stefano
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (11): : 776 - 777
  • [5] Undiagnosed dysglycaemia and inflammation in cardiovascular disease
    Johansen, O. E.
    Birkeland, K. I.
    Brustad, E.
    Aaser, E.
    Lindahl, A. K.
    Midha, R.
    Ueland, T.
    Aukrust, P.
    Gullestad, L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (08) : 544 - 551
  • [6] Undiagnosed dysglycaemia and inflammation in cardiovascular disease
    Johansen, O.
    Birkeland, K. I.
    Brustad, E.
    Aaser, E.
    Lindahl, A-K.
    Midha, R.
    Ueland, T.
    Aukrust, P.
    Gullestad, L.
    DIABETOLOGIA, 2006, 49 : 55 - 56
  • [7] The Association of Dysglycaemia and Cardiovascular Disease in Patients with Metabolic Syndrome
    Gong, W.
    Yang, Z.
    Ye, W.
    Du, Y.
    Lu, B.
    Wang, M.
    Li, Q.
    Zhang, W.
    Pan, Y.
    Feng, X.
    Zhou, W.
    Zhang, Y.
    Wen, J.
    Yang, Z.
    Yang, Y.
    Zhu, X.
    Hu, R.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (05) : 1486 - 1492
  • [8] Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor?
    Ferrannini, Giulia
    Svenungsson, Elisabet
    Kjellstrom, Barbro
    Elvin, Kerstin
    Grosso, Giorgia
    Nasman, Per
    Ryden, Lars
    Norhammar, Anna
    DIABETES & VASCULAR DISEASE RESEARCH, 2020, 17 (03):
  • [9] Increased cardiovascular risk after pre-eclampsia in women with dysglycaemia
    McDonald, S. D.
    Yusuf, S.
    Walsh, M. W.
    Lonn, E.
    Teo, K.
    Anand, S. S.
    Pogue, J.
    Islam, S.
    Devereaux, P. J.
    Gerstein, H. C.
    DIABETIC MEDICINE, 2013, 30 (01) : E1 - E7
  • [10] Dysglycaemia as a cause of cardiovascular outcomes
    Hertzel C. Gerstein
    Nature Reviews Endocrinology, 2015, 11 : 508 - 510
12345